GXL 0.00% $5.54 greencross limited

News: GXL Greencross Sees FY2018 Underlying EBITDA Between $97 Mln And $100 Mln, page-53

  1. 200 Posts.
    lightbulb Created with Sketch. 1
    Why would they sell the vet clinics ?
    If Mars turn up offering 19x Ebitda like they did for VCA then that would make sense.
    The vets are critical to the cross selling between vet and retail
 
watchlist Created with Sketch. Add GXL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.